By Laura Serrano / July 29, 2022
In April, Nuwellis was in Denver for the annual Pediatric Academic Societies (PAS) meeting, where the use of Aquadex for pediatric patients was the focus of three abstracts. Together, these papers are adding data to the growing body of research supporting the negative impact of fluid overload and the positive potential of ultrafiltration for children and babies.
Nuwellis was also proud to support the Children’s Minnesota StarGala in April, benefitting the health system’s neonatal program. Community building starts at home, and we’re honored to partner with the children’s health system in our own backyard here in the Twin Cities to support parents and newborns in Minnesota.
A few weeks later in early May, Nuwellis traveled to Atlanta for the PC4 hybrid Spring Conference sponsored by Children’s Atlanta. PC4 stands for Pediatric Cardiac Critical Care Consortium, and the event was focused on the future of cardiac care for children. At PC4 we discussed Aquadex and the current needs in pediatric fluid management with over 100 healthcare professionals in the field.
Children with pediatric kidney disease go through a lot already. They need the fluid removal process to be as gentle and precise as possible. For critically ill pediatric patients, managing fluid balance is crucial in reducing the risk of morbidity and mortality. Aquadex SmartFlow allows for gentler, more precise fluid removal that is adjustable to the patient.
A customizable rate of fluid removal means Aquadex can achieve the needed fluid balance in pediatric patients with less extracorporeal volume (ECV), or blood outside the body. Minimizing ECV is crucial for children especially, because they’re so much smaller than adult patients, with far less blood to spare. Aquadex is cleared by the FDA for use in adults and pediatric patients weighing 20 kg (44 lbs.) or more.
“Ultrafiltration using the Aquadex system provides an easy to use, safe and effective therapy for managing fluid balance in pediatric patients,” said David Askenazi, MD, MSPH and director of the Pediatric and Infant Center for Acute Nephrology (PICAN) at Children’s of Alabama and University of Alabama at Birmingham. “I’m grateful for the commitment from the company and I’m proud to partner with Nuwellis to provide meaningful data that helps the medical community determine when and how to implement Aquadex for those who suffer from pediatric kidney disease.”
 Wang S, et al. Perfusion., vol. 27, no. 5, pp. 438-46, Sep 2012.
 Askenazi D, et al. Pediatr Nephrol., vol. 31, no. 5, pp. 853-860, May 2016.
 Chakravarti S, et al. Pediatr Rep., vol. 8, no. 2, p. 6596, 23 Jun 2016.
 Raina R, et al. PLoS ONE, vol. 12, no. 5, p. e0178233, 30 May 2017.